Literature DB >> 25830831

Mechanisms and clinical consequences of acute lung injury.

Vito Fanelli1, V Marco Ranieri.   

Abstract

Acute respiratory distress syndrome (ARDS) was first described in 1967, and since then there have been a large number of studies addressing its pathogenesis and therapies. Despite intense research efforts, very few therapies for ARDS have been shown to be effective other than the use of lung protection strategies. The scarcity of therapeutic choices is related to the intricate pathogenesis of the syndrome and to insensitive and aspecific criteria to diagnose this profound acute respiratory failure. The aim of this paper is to summarize advances of new ARDS definitions and provide an overview of new relevant signaling pathways that mediate acute lung injury.

Entities:  

Keywords:  acute respiratory distress syndrome; alveolar edema; lung injury; vascular permeability

Mesh:

Year:  2015        PMID: 25830831     DOI: 10.1513/AnnalsATS.201407-340MG

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  49 in total

1.  Cortical Actin Dynamics in Endothelial Permeability.

Authors:  Patrick Belvitch; Yu Maw Htwe; Mary E Brown; Steven Dudek
Journal:  Curr Top Membr       Date:  2018-10-15       Impact factor: 3.049

2.  Effects of Tec Tyrosine Kinase Inhibition on the Inflammatory Response of Severe Acute Pancreatitis-Associated Acute Lung Injury in Mice.

Authors:  Yiteng Meng; Shuo Sha; Jing Yang; Hongbo Ren
Journal:  Dig Dis Sci       Date:  2019-02-14       Impact factor: 3.199

3.  In vivo imaging of the progression of acute lung injury using hyperpolarized [1-13 C] pyruvate.

Authors:  Mehrdad Pourfathi; Yi Xin; Stephen J Kadlecek; Maurizio F Cereda; Harrilla Profka; Hooman Hamedani; Sarmad M Siddiqui; Kai Ruppert; Nicholas A Drachman; Jennia N Rajaei; Rahim R Rizi
Journal:  Magn Reson Med       Date:  2017-01-11       Impact factor: 4.668

Review 4.  The role of stretch-activated ion channels in acute respiratory distress syndrome: finally a new target?

Authors:  Andreas Schwingshackl
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-08-12       Impact factor: 5.464

5.  Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.

Authors:  Xiaofeng Niu; Fang Liu; Weifeng Li; Wenbing Zhi; Hailin Zhang; Xiumei Wang; Zehong He
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

Review 6.  Peroxiredoxins and Beyond; Redox Systems Regulating Lung Physiology and Disease.

Authors:  Evan A Elko; Brian Cunniff; David J Seward; Shi Biao Chia; Reem Aboushousha; Cheryl van de Wetering; Jos van der Velden; Allison Manuel; Arti Shukla; Nicholas H Heintz; Vikas Anathy; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Antioxid Redox Signal       Date:  2019-04-05       Impact factor: 8.401

7.  Publication trends of research on acute lung injury and acute respiration distress syndrome during 2009-2019: a 10-year bibliometric analysis.

Authors:  Chen Wang; Xuren Wang; Xisha Long; Demeng Xia; Daofeng Ben; Yin Wang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 8.  Modulation of cell signaling pathways by Phyllanthus amarus and its major constituents: potential role in the prevention and treatment of inflammation and cancer.

Authors:  Hemavathy Harikrishnan; Ibrahim Jantan; Akilandeshwari Alagan; Md Areeful Haque
Journal:  Inflammopharmacology       Date:  2019-12-02       Impact factor: 4.473

9.  Sphingolipids Signaling in Lamellipodia Formation and Enhancement of Endothelial Barrier Function.

Authors:  Panfeng Fu; Mark Shaaya; Anantha Harijith; Jeffrey R Jacobson; Andrei Karginov; Viswanathan Natarajan
Journal:  Curr Top Membr       Date:  2018-09-27       Impact factor: 3.049

Review 10.  Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis.

Authors:  Wei Wang; Ni Yang; Ri Wen; Chun-Feng Liu; Tie-Ning Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-05-12       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.